ID

33089

Description

Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions; ODM derived from: https://clinicaltrials.gov/show/NCT00832481

Link

https://clinicaltrials.gov/show/NCT00832481

Keywords

Versions (1)
  1. 11/26/18 11/26/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 26, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes NCT00832481

English

Eligibility Type 2 Diabetes NCT00832481

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. informed consent obtained before any trial-related activities. (trial- related activities are any procedure that would not have been performed during normal management of the subject.)
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
2. ages between 20-90 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
3. bmi between 18.5 and 30 kg/m2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
4. newly diagnosed type 2 diabetes. type 2 diabetes is in accordance with who criteria 1999
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
5. the history of diabetes less than 6 months
Description

Diabetes Mellitus Disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0872146
6. hba1c <10%.
Description

Hemoglobin A1c measurement

Data type

boolean

Alias
UMLS CUI [1]
C0474680
7. only on diet and/or exercise, oad or insulin naïve subjects
Description

Diet therapy | Exercise | Antidiabetics Oral Absent | Insulin Absent

Data type

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0015259
UMLS CUI [3,1]
C0935929
UMLS CUI [3,2]
C1527415
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0021641
UMLS CUI [4,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. any history of oad or insulin therapy preceding this trial.
Description

Antidiabetics Oral | Insulin regime

Data type

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0557978
2. type 1 diabetic subjects, including lada
Description

Diabetes Mellitus, Insulin-Dependent | Latent Autoimmune Diabetes in Adults

Data type

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C1739108
3. pregnant, breast-feeding or the intention of becoming pregnant or not using adequate contraceptive measures (adequate contraceptive measures are sterilisation, iud, oral contraceptives or barrier methods) before and/or during the trial.
Description

Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent | Female Sterilization | Intrauterine Devices | Contraceptives, Oral | Contraception, Barrier

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C0015787
UMLS CUI [6]
C0021900
UMLS CUI [7]
C0009905
UMLS CUI [8]
C0004764
4. impaired hepatic function (alt > 2.5 times upper limit of local laboratories normal ranges)
Description

Liver Dysfunction | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0151905
5. impaired renal function, defined as serum creatinine ≥ 1.5 mg/dl.
Description

Renal Insufficiency | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
6. use of systemic or inhaled glucocorticoids or other medication known to interfere with glucose metabolism.
Description

Glucocorticoids, Systemic | Glucocorticoids Inhalation | Pharmaceutical Preparations Interferes with Glucose metabolism

Data type

boolean

Alias
UMLS CUI [1]
C3540777
UMLS CUI [2,1]
C0017710
UMLS CUI [2,2]
C0205535
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0596620
7. recently had acute diabetic complications
Description

Acute complication with diabetes mellitus

Data type

boolean

Alias
UMLS CUI [1]
C4546244
8. mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
Description

Mental handicap Comprehension Excluded | Comprehension Unwilling | Language Barriers Comprehension Excluded | Mental handicap Cooperation Excluded | Cooperation Unwilling | Language Barriers Cooperation Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C1306341
UMLS CUI [1,2]
C0162340
UMLS CUI [1,3]
C0332196
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C0558080
UMLS CUI [3,1]
C0237167
UMLS CUI [3,2]
C0162340
UMLS CUI [3,3]
C0332196
UMLS CUI [4,1]
C1306341
UMLS CUI [4,2]
C0392337
UMLS CUI [4,3]
C0332196
UMLS CUI [5,1]
C0392337
UMLS CUI [5,2]
C0558080
UMLS CUI [6,1]
C0237167
UMLS CUI [6,2]
C0392337
UMLS CUI [6,3]
C0332196
9. recently had operation, injury, inflammation and other stress conditions.
Description

Operative Surgical Procedures | Injury | Inflammation | Stress

Data type

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2]
C3263723
UMLS CUI [3]
C0021368
UMLS CUI [4]
C0038435
10. recently had cardiac disease as following:
Description

Heart Disease

Data type

boolean

Alias
UMLS CUI [1]
C0018799
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes NCT00832481

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. informed consent obtained before any trial-related activities. (trial- related activities are any procedure that would not have been performed during normal management of the subject.)
boolean
C0021430 (UMLS CUI [1])
Age
Item
2. ages between 20-90 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
3. bmi between 18.5 and 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
4. newly diagnosed type 2 diabetes. type 2 diabetes is in accordance with who criteria 1999
boolean
C0011860 (UMLS CUI [1])
Diabetes Mellitus Disease length
Item
5. the history of diabetes less than 6 months
boolean
C0011849 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
6. hba1c <10%.
boolean
C0474680 (UMLS CUI [1])
Diet therapy | Exercise | Antidiabetics Oral Absent | Insulin Absent
Item
7. only on diet and/or exercise, oad or insulin naïve subjects
boolean
C0012159 (UMLS CUI [1])
C0015259 (UMLS CUI [2])
C0935929 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0021641 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Item Group
C0680251 (UMLS CUI)
Antidiabetics Oral | Insulin regime
Item
1. any history of oad or insulin therapy preceding this trial.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0557978 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent | Latent Autoimmune Diabetes in Adults
Item
2. type 1 diabetic subjects, including lada
boolean
C0011854 (UMLS CUI [1])
C1739108 (UMLS CUI [2])
Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent | Female Sterilization | Intrauterine Devices | Contraceptives, Oral | Contraception, Barrier
Item
3. pregnant, breast-feeding or the intention of becoming pregnant or not using adequate contraceptive measures (adequate contraceptive measures are sterilisation, iud, oral contraceptives or barrier methods) before and/or during the trial.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0015787 (UMLS CUI [5])
C0021900 (UMLS CUI [6])
C0009905 (UMLS CUI [7])
C0004764 (UMLS CUI [8])
Liver Dysfunction | Alanine aminotransferase increased
Item
4. impaired hepatic function (alt > 2.5 times upper limit of local laboratories normal ranges)
boolean
C0086565 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Renal Insufficiency | Creatinine measurement, serum
Item
5. impaired renal function, defined as serum creatinine ≥ 1.5 mg/dl.
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Glucocorticoids, Systemic | Glucocorticoids Inhalation | Pharmaceutical Preparations Interferes with Glucose metabolism
Item
6. use of systemic or inhaled glucocorticoids or other medication known to interfere with glucose metabolism.
boolean
C3540777 (UMLS CUI [1])
C0017710 (UMLS CUI [2,1])
C0205535 (UMLS CUI [2,2])
C0013227 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0596620 (UMLS CUI [3,3])
Acute complication with diabetes mellitus
Item
7. recently had acute diabetic complications
boolean
C4546244 (UMLS CUI [1])
Mental handicap Comprehension Excluded | Comprehension Unwilling | Language Barriers Comprehension Excluded | Mental handicap Cooperation Excluded | Cooperation Unwilling | Language Barriers Cooperation Excluded
Item
8. mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
boolean
C1306341 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0162340 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C0237167 (UMLS CUI [3,1])
C0162340 (UMLS CUI [3,2])
C0332196 (UMLS CUI [3,3])
C1306341 (UMLS CUI [4,1])
C0392337 (UMLS CUI [4,2])
C0332196 (UMLS CUI [4,3])
C0392337 (UMLS CUI [5,1])
C0558080 (UMLS CUI [5,2])
C0237167 (UMLS CUI [6,1])
C0392337 (UMLS CUI [6,2])
C0332196 (UMLS CUI [6,3])
Operative Surgical Procedures | Injury | Inflammation | Stress
Item
9. recently had operation, injury, inflammation and other stress conditions.
boolean
C0543467 (UMLS CUI [1])
C3263723 (UMLS CUI [2])
C0021368 (UMLS CUI [3])
C0038435 (UMLS CUI [4])
Heart Disease
Item
10. recently had cardiac disease as following:
boolean
C0018799 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial